Bridgeway Capital Management, LLC Ayala Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.38 - $0.71 $9,500 - $17,750	-25,000 Reduced 30.53%	56,900 $22,000
Q1 2022 May 16, 2022	BUY	$3.5 - $9.11 $13,650 - $35,529	3,900 Added 5.0%	81,900 $326,000
Q4 2021 Feb 14, 2022	BUY	$8.32 - $12.45 $208,000 - $311,250	25,000 Added 47.17%	78,000 $664,000
Q3 2021 Nov 15, 2021	BUY	$8.13 - $14.09 $171,038 - $296,425	21,038 Added 65.82%	53,000 $601,000
Q2 2021 Aug 16, 2021	SELL	$9.2 - $11.3 $27,949 - $34,329	-3,038 Reduced 8.68%	31,962 $326,000
Q1 2021 May 17, 2021	BUY	$10.72 - $22.0 $375,200 - $770,000	35,000 New	35,000 $382,000

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.